GRAMD1B and fungal infectious disease: LAmB showed promising effects against several fungal infections such as mucormycosis [280,281,282], aspergillosis [283,284,285], candidiasis [286,287,288], Candida meningoencephalitis [289], cryptococcosis [88,290], histoplasmosis [291], and other uncommon but highly invasive mycoses, such as fusariosis [292].